WesBanco Bank’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$862K Sell
4,067
-25
-0.6% -$4.91K 0.02% 412
2026
Q1
$802K Sell
4,092
-118
-3% -$22.9K 0.02% 408
2025
Q4
$731K Sell
4,210
-394
-9% -$71.7K 0.02% 411
2025
Q3
$877K Buy
4,604
+812
+21% +$144K 0.02% 390
2025
Q2
$681K Buy
3,792
+10
+0.3% +$1.74K 0.02% 414
2025
Q1
$640K Sell
3,782
-20
-0.5% -$3.29K 0.02% 384
2024
Q4
$574K Buy
3,802
+23
+0.6% +$3.58K 0.02% 405
2024
Q3
$587K Sell
3,779
-6
-0.2% -$896 0.02% 408
2024
Q2
$518K Sell
3,785
-5
-0.1% -$685 0.02% 407
2024
Q1
$504K Buy
3,790
+1,348
+55% +$175K 0.02% 413
2023
Q4
$337K Sell
2,442
-1,288
-35% -$169K 0.02% 305
2023
Q3
$455K Sell
3,730
-10
-0.3% -$1.33K 0.02% 422
2023
Q2
$526K Sell
3,740
-140
-4% -$19.3K 0.02% 399
2023
Q1
$549K Sell
3,880
-258
-6% -$36.9K 0.02% 391
2022
Q4
$647K Buy
4,138
+1,685
+69% +$242K 0.03% 353
2022
Q3
$301K Sell
2,453
-1,690
-41% -$223K 0.02% 299
2022
Q2
$551K Sell
4,143
-450
-10% -$61.3K 0.02% 380
2022
Q1
$629K Sell
4,593
-129
-3% -$18K 0.02% 380
2021
Q4
$817K Buy
4,722
+215
+5% +$32.7K 0.03% 338
2021
Q3
$655K Buy
4,507
+249
+6% +$36.4K 0.03% 371
2021
Q2
$562K Sell
4,258
-500
-11% -$65.5K 0.02% 400
2021
Q1
$611K Buy
+4,758
New +$586K 0.02% 363
2020
Q3
$549K Hold
4,800
0.03% 349
2020
Q2
$547K Hold
4,800
0.03% 336
2020
Q1
$386K Sell
4,800
-248
-5% -$25.7K 0.02% 364
2019
Q4
$539K Buy
5,048
+228
+5% +$23.8K 0.02% 365
2019
Q3
$516K Hold
4,820
0.03% 368
2019
Q2
$491K Sell
4,820
-100
-2% -$9.61K 0.02% 375
2019
Q1
$443K Sell
4,920
-207
-4% -$17.9K 0.02% 384
2018
Q4
$427K Sell
5,127
-7
-0.1% -$656 0.03% 349
2018
Q3
$554K Sell
5,134
-349
-6% -$38.3K 0.03% 351
2018
Q2
$603K Sell
5,483
-200
-4% -$20.8K 0.03% 323
2018
Q1
$570K Sell
5,683
-24
-0.4% -$2.46K 0.03% 337
2017
Q4
$562K Sell
5,707
-1
-0% -$95 0.04% 246
2017
Q3
$534K Hold
5,708
0.03% 339
2017
Q2
$634K Buy
5,708
+250
+5% +$26.4K 0.03% 304
2017
Q1
$536K Hold
5,458
0.03% 315
2016
Q4
$502K Hold
5,458
0.03% 319
2016
Q3
$462K Hold
5,458
0.03% 334
2016
Q2
$444K Sell
5,458
-300
-5% -$22.8K 0.03% 343
2016
Q1
$412K Hold
5,758
0.02% 339
2015
Q4
$409K Hold
5,758
0.02% 338
2015
Q3
$354K Hold
5,758
0.02% 361
2015
Q2
$418K Sell
5,758
-400
-6% -$29.5K 0.02% 357
2015
Q1
$473K Hold
6,158
0.03% 340
2014
Q4
$413K Hold
6,158
0.02% 362
2014
Q3
$374K Hold
6,158
0.02% 384
2014
Q2
$361K Hold
6,158
0.02% 382
2014
Q1
$357K Sell
6,158
-300
-5% -$16.1K 0.02% 392
2013
Q4
$345K Sell
6,458
-250
-4% -$14.8K 0.02% 394
2013
Q3
$414K Buy
6,708
+1,700
+34% +$102K 0.03% 363
2013
Q2
$304K Buy
+5,008
New +$298K 0.02% 398

Other funds holding DGX

WesBanco Bank's DGX Position: Q2 2026 in Review

WesBanco Bank reduced its Quest Diagnostics (DGX) stake by 0.61% in Q2 2026, selling an estimated $4.91K and leaving 4,067 shares worth $862K. The position accounts for 0.02% of the portfolio, ranked #412.

WesBanco Bank first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $877K in Q3 2025. 478 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • WesBanco Bank held 4,067 shares of Quest Diagnostics worth $862K as of Q2 2026.
  • WesBanco Bank sold 25 Quest Diagnostics shares in Q2 2026, an estimated $4.91K.
  • Quest Diagnostics made up 0.02% of WesBanco Bank's portfolio in Q2 2026, its #412 holding.
  • WesBanco Bank first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • WesBanco Bank's Quest Diagnostics position peaked at $877K in Q3 2025.
  • 478 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on WesBanco Bank's 13F filing for Q2 2026, filed 28 Jul 2026.